Bernd Heinrich

9PUBLICATIONS
32CO-AUTHORS
Disease surveillanceMolecular targetsHaematological tumoursInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 22, 2026
[Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)].

|Aug 01, 2024
FTO/m6A/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment?

Bernd Heinrich, Francisco Javier Cubero

|Feb 21, 2024
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature.

Sophie Anna Engelskircher, Po-Chun Chen, Benedikt Strunz

|Jan 09, 2023
[Innate and adaptive immunity in the context of non-alcoholic fatty liver disease].

Bernd Heinrich

|Aug 03, 2021
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.

Bernd Heinrich, E Michael Gertz, Alejandro A Schäffer

|Jul 01, 2021
Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response.

Benjamin Ruf, Vanessa V Catania, Simon Wabitsch

Pageof 2

Frequent Collaborators

5 joint publications

Lichun Ma

4 joint publications

Tim F Greten

3 joint publications

Benjamin Ruf

2 joint publications

Xin Wei Wang